Bail denied in black marketing of Remdesivir and Favipiravir by Bombay High Court .   In the Matter of : Pravin Sukhraj Jain Vs The State of Mahrastra in ANT. BAIL APPLICATION (ST) NO.2109 OF 2020 held that:- This will ensure early access of Remdesivir for treatment of severe COVID patients in the country under the Restricted Emergency Use. Favipiravir Tablet has been approved for manufacture and marketing on 19.6.2020. Both Remdesivir and Favipiravir formulations are required to be sold under the prescription of medical specialists only. Further, Remdesivir formulations are required to be supplied for use only to the hospital institutions to ensure proper use of the drug as recommended. In both the cases, informed consent of the patient or his / her representative in the prescribed form is mandatory before initiating the treatment." 9 Upon reading these two communications along with the provisions of the Drugs (Prices Control) Order, 2013, it may be stated ...